(en) Ono, Hiroko et al., « Effect of the Norepinephrine Transporter (NET) Inhibition on m-Opioid Receptor (MOR)-Induced Anti-nociception in a Bone Cancer Pain Model », J Pharmacol Sci 1, vol. 125, no 3, , p. 264 – 273 (DOI10.1254/jphs.14081FP, lire en ligne, consulté le )
Bernd Lange, Melanie Sohns, José Tempero et Christian Elling, « Efficacy and safety of tapentadol prolonged release formulation in the treatment of elderly patients with moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo-, and active-controlled trials », Current Medical Research and Opinion, vol. 34, no 12, , p. 2113–2123 (ISSN1473-4877, PMID30200781, DOI10.1080/03007995.2018.1520085, lire en ligne, consulté le )
(en) Miho Takemura, Kazuyuki Niki, Yoshiaki Okamoto, Yoshinobu Matsuda, Takahito Omae, Tatsuya Takagi et Mikiko Ueda, « Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone », Biological and Pharmaceutical Bulletin, vol. 44, no 9, , p. 1286-1293 (ISSN0918-6158, e-ISSN1347-5215, DOI10.1248/bpb.b21-00212, lire en ligne, consulté le )
doi.org
(en) Ono, Hiroko et al., « Effect of the Norepinephrine Transporter (NET) Inhibition on m-Opioid Receptor (MOR)-Induced Anti-nociception in a Bone Cancer Pain Model », J Pharmacol Sci 1, vol. 125, no 3, , p. 264 – 273 (DOI10.1254/jphs.14081FP, lire en ligne, consulté le )
Bernd Lange, Melanie Sohns, José Tempero et Christian Elling, « Efficacy and safety of tapentadol prolonged release formulation in the treatment of elderly patients with moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo-, and active-controlled trials », Current Medical Research and Opinion, vol. 34, no 12, , p. 2113–2123 (ISSN1473-4877, PMID30200781, DOI10.1080/03007995.2018.1520085, lire en ligne, consulté le )
(en) Miho Takemura, Kazuyuki Niki, Yoshiaki Okamoto, Yoshinobu Matsuda, Takahito Omae, Tatsuya Takagi et Mikiko Ueda, « Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone », Biological and Pharmaceutical Bulletin, vol. 44, no 9, , p. 1286-1293 (ISSN0918-6158, e-ISSN1347-5215, DOI10.1248/bpb.b21-00212, lire en ligne, consulté le )
jst.go.jp
jstage.jst.go.jp
(en) Miho Takemura, Kazuyuki Niki, Yoshiaki Okamoto, Yoshinobu Matsuda, Takahito Omae, Tatsuya Takagi et Mikiko Ueda, « Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone », Biological and Pharmaceutical Bulletin, vol. 44, no 9, , p. 1286-1293 (ISSN0918-6158, e-ISSN1347-5215, DOI10.1248/bpb.b21-00212, lire en ligne, consulté le )
medicinescomplete.com
(en) A. Brayfield,, ed. (14 novembre 2011). Tapentadol, Martindale: The Complete Drug Reference. Pharmaceutical Press. consulté le 2 avril 2014.
Bernd Lange, Melanie Sohns, José Tempero et Christian Elling, « Efficacy and safety of tapentadol prolonged release formulation in the treatment of elderly patients with moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo-, and active-controlled trials », Current Medical Research and Opinion, vol. 34, no 12, , p. 2113–2123 (ISSN1473-4877, PMID30200781, DOI10.1080/03007995.2018.1520085, lire en ligne, consulté le )
pubmed.ncbi.nlm.nih.gov
Bernd Lange, Melanie Sohns, José Tempero et Christian Elling, « Efficacy and safety of tapentadol prolonged release formulation in the treatment of elderly patients with moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo-, and active-controlled trials », Current Medical Research and Opinion, vol. 34, no 12, , p. 2113–2123 (ISSN1473-4877, PMID30200781, DOI10.1080/03007995.2018.1520085, lire en ligne, consulté le )
